scholarly article | Q13442814 |
P2093 | author name string | Jong-Il Kim | |
Jong Hee Chae | |||
Soo Yeon Kim | |||
Byung Chan Lim | |||
Hee Hwang | |||
Ki Joong Kim | |||
Hunmin Kim | |||
Se Song Jang | |||
P2860 | cites work | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | Q50594407 |
High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders. | Q55022100 | ||
Targeted next generation sequencing as a diagnostic tool in epileptic disorders | Q84182666 | ||
Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort | Q91856722 | ||
De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies | Q24563008 | ||
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. | Q24602558 | ||
De novo mutations in epileptic encephalopathies | Q24621776 | ||
Novel mutations in ATP1A3 associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly | Q27312451 | ||
Understanding Genotypes and Phenotypes in Epileptic Encephalopathies | Q28080066 | ||
Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009 | Q28274778 | ||
Copy number variation detection and genotyping from exome sequence data | Q30422583 | ||
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples | Q34327021 | ||
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Q34465792 | ||
Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform | Q35079979 | ||
Copy number variation plays an important role in clinical epilepsy | Q35804664 | ||
Gene Mutation Analysis in 253 Chinese Children with Unexplained Epilepsy and Intellectual/Developmental Disabilities | Q36257814 | ||
Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis. | Q36886682 | ||
De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies | Q37152969 | ||
Disease-targeted sequencing: a cornerstone in the clinic | Q37205397 | ||
Targeted sequencing of 351 candidate genes for epileptic encephalopathy in a large cohort of patients. | Q37257128 | ||
Amplicon Resequencing Identified Parental Mosaicism for Approximately 10% of "de novo" SCN1A Mutations in Children with Dravet Syndrome | Q37279405 | ||
Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies | Q37356251 | ||
Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies | Q38781650 | ||
Diagnostic Targeted Resequencing in 349 Patients with Drug-Resistant Pediatric Epilepsies Identifies Causative Mutations in 30 Different Genes. | Q39172712 | ||
Incidence and outcome of epilepsy syndromes with onset in the first year of life: A retrospective population-based study | Q39441869 | ||
Pitfalls in genetic testing: the story of missed SCN1A mutations | Q39552867 | ||
Severe Neonatal Epileptic Encephalopathy and KCNQ2 Mutation: Neuropathological Substrate? | Q41612845 | ||
Targeted capture and sequencing for detection of mutations causing early onset epileptic encephalopathy | Q45212007 | ||
The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification. | Q46356948 | ||
Efficient strategy for the molecular diagnosis of intractable early-onset epilepsy using targeted gene sequencing. | Q47825681 | ||
Molecular diagnosis of patients with epilepsy and developmental delay using a customized panel of epilepsy genes | Q48585931 | ||
Paediatric genomics: diagnosing rare disease in children | Q49886189 | ||
Diagnostic Yield From 339 Epilepsy Patients Screened on a Clinical Gene Panel. | Q50065261 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | seizure | Q6279182 |
P304 | page(s) | 988 | |
P577 | publication date | 2019-09-13 | |
P1433 | published in | Frontiers in Neurology | Q15817039 |
P1476 | title | Diagnostic Yield of Epilepsy Panel Testing in Patients With Seizure Onset Within the First Year of Life | |
P478 | volume | 10 |
Q98218002 | Nonseizure consequences of Dravet syndrome, KCNQ2-DEE, KCNB1-DEE, Lennox-Gastaut syndrome, ESES: A functional framework | cites work | P2860 |
Search more.